Back to Supplement Finder

DSIP - Delta Sleep-Inducing Peptide X 5mg

Sold by FMI Health

INR 7,255.00

View at FMI Health
Store
fmihealth.com
Brand
Biolongevity Labs
Product type
Peptides
Collected
2026-11-20

From the retailer

Retailer description retrieved 2026-11-20. Claims are the retailer’s, not independently verified.

Description--DSIP (Delta Sleep‑Inducing Peptide): It is a naturally occurring nonapeptide (Trp‑Ala‑Gly‑Gly‑Asp‑Ala‑Ser‑Gly‑Glu) first isolated in rabbits in the 1970s. It is named for its ability to promote slow‑wave (delta) sleep in experimental animals and has been studied across species including humans, rabbits, rats, and mice. Research suggests DSIP may play broader roles in neuroendocrine regulation, stress response, pain modulation, and immune function.

 

Mechanistic Claims

  • Sleep Regulation: Enhances delta and spindle EEG activity, supporting deep sleep stages.
  • Neuroendocrine Effects: Investigated for modulation of hypothalamic–pituitary function and stress response.
  • Pain Modulation: Preclinical studies suggest potential analgesic properties.
  • Immune Function: Early research indicates possible immunomodulatory activity.
  • Systemic Role: Mechanism of action remains under investigation, with evidence pointing to multiple physiological pathways.

 

Research Applications

  • Sleep physiology and insomnia research
  • Neuroendocrine and stress regulation studies
  • Pain and nociception models
  • Immune system investigations
  • Exploratory therapeutic studies in depression and chronic conditions

 

DSIP Research

Delta sleep-inducing peptide (DSIP) is a neuropeptide consisting of nine amino acids (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) that was first isolated from the cerebral venous blood of rabbits during sleep in the 1970s.

 

As its name suggests, DSIP was initially identified for its apparent ability to promote slow-wave (delta) sleep, which is the deepest stage of non-REM sleep. Subsequent research has revealed its effects may be more complex and potentially extend beyond sleep regulation.

DSIP has been studied for various potential physiological roles, including:

  • Stress response and adaptation
  • Pain modulation
  • Immune system regulation
  • Antioxidant properties
  • Effects on endocrine function

DSIP has been investigated for potential applications in sleep disorders, pain management, and substance withdrawal syndromes.

 

DSIP and Sleep Regulation

DSIP is known for its ability to induce delta sleep, a type of non-REM sleep characterized by slow-wave EEG patterns. It has been shown to promote sleep in several species, including rabbits, rats, mice, and humans, with varying effects on REM sleep in 

DSIP has been shown to influence neurotransmitter levels, including serotonin (5-HT), glutamate, dopamine, and melatonin, which are crucial for sleep 

 

 

 

  1. Pollard, B., & Pomfrett, C. (2001). Delta sleep-inducing peptide.. European journal of anaesthesiology, 18 7, 419-22 . .
  2. Mu, X., Qu, L., Yin, L., Wang, L., Liu, X., & Liu, D. (2024). Pichia pastoris secreted peptides crossing the blood-brain barrier and DSIP fusion peptide efficacy in PCPA-induced insomnia mouse models. Frontiers in Pharmacology, 15. .
  3. Graf, M., & Kastin, A. (1986). Delta-sleep-inducing peptide (DSIP): An update. Peptides, 7, 1165-1187. .
  4. Schneider-Helmert, D., & Schoenenberger, G. (1983). Effects of DSIP in man. Multifunctional psychophysiological properties besides induction of natural sleep.. Neuropsychobiology, 9 4, 197-206 . .
  5. Kovalzon, V., & Strekalova, T. (2006). Delta sleep‐inducing peptide (DSIP): a still unresolved riddle. Journal of Neurochemistry, 97. .
  6. Larbig, W., Gerber, W., & Schoenenberger, G. (1987). Peptidergic Pain Reducing Effects Of The Delta-Sleep-Inducing Peptide (Dsip) In Headache And Other Pain Syndroms. Cephalalgia, 7, 46 – 48. .
  7. Larbig, W., Gerber, W., Kluck, M., & Schoenenberger, G. (1984). Therapeutic effects of delta-sleep-inducing peptide (DSIP) in patients with chronic, pronounced pain episodes. A clinical pilot study.. European neurology, 23 5, 372-85 . .
  8. Yehuda, S., & Carasso, R. (1987). The effects of DSIP on pain threshold during light and dark periods in rats are not naloxone-sensitive.. The International journal of neuroscience, 37 1-2, 85-8 . .
  9. Dick, P., Grandjean, M., & Tissot, R. (1983). Successful treatment of withdrawal symptoms with delta sleep-inducing peptide, a neuropeptide with potential agonistic activity on opiate receptors.. Neuropsychobiology, 10 4, 205-8 . .
  10. Dick, P., Costa, C., Fayolle, K., Grandjean, M., Khoshbeen, A., & Tissot, R. (1984). DSIP in the treatment of withdrawal syndromes from alcohol and opiates.. European neurology, 23 5, 364-71 . .


Label--Peptide Information

Property Value
Peptide Sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
Molecular Formula C35H48N10O15
Molecular Weight 848.8 g/mol
CAS Number 62568-57-4
PubChem CID 68816
Synonyms Emideltide, 62568-57-4, DELTA SLEEP INDUCING PEPTIDE, DSIP nonapeptide

Dosage--This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.